A dose-response study of intravenous enoximone in congestive heart failure
- 14 August 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (5) , 31-36
- https://doi.org/10.1016/0002-9149(87)90522-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1986
- Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failureAmerican Heart Journal, 1984
- Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patientsJournal of the American College of Cardiology, 1984
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- Hemodynamic Effects of MDL 17,043, a New Cardiotonic Agent, in Patients with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1983
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983